- Home
- Companies
- canada saskatchewan
- disease early
Refine by
Disease Early Suppliers Serving Saskatchewan
51 companies found
based inSyracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
based inShibuya-ku, JAPAN
Nikkiso has been a pioneer in Japan developing and introducing groundbreaking technologies in highly specialized fields ranging from specialty pumps for the manufacturing industry to carbon fiber-reinforced plastic components for aircraft and ...
As a pioneer of dialysis machines, Nikkiso has been moving forward with the development of Hemodialysis . In order to propose a comfortable therapeutic environment for everyone who requires Hemodialysis, operations from development, manufacturing ...
based inBlenheim, NEW ZEALAND
DNAiTECH is a leading organization involved in the development of cutting-edge diagnostic technologies. Their expertise in loop-mediated isothermal amplification (LAMP) technology combined with CRISPR enables the creation of precise point-of-care ...
DNAiTECH is advancing the field of in-field and point-of-care diagnostics with the development of innovative testing instruments. Their Gen3 platform, slated for release in 2024, aims to meet the World Health Organization's ASSURED criteria, ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for ...
based inFramingham, MASSACHUSETTS (USA)
Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...
Kephera is developing a new test for Lyme disease, supported by a grant from the National Institute of Allergy and Infectious Diseases. Lyme disease has become the most common vector-borne disease in the U.S., with over 300,000 cases per year ...
based inOttawa, ONTARIO (CANADA)
MedBiome Inc. was launched in 2018 as the result of technologies developed at the University of Ottawa. MedBiome focuses on the development of Precision Microbiome Therapeutics and Precision Microbiome Nutrition that target the production of ...
based inSt. Louis, MISSOURI (USA)
C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...
The PrecivityAD™ test is an innovative new blood test intended for use in patients with cognitive impairment. The test aims to help physicians better determine the presence or absence of amyloid plaques in the brain, a hallmark sign of ...
based inNorcross, GEORGIA (US) (USA)
Create a revolution in medical imaging through our advanced Computed Tomography technology. We believe our Koning Breast CT will dramatically improve the way clinicians visualize and evaluate breast tissue. Future versions of our technology are ...
based inAbercynon, UNITED KINGDOM
Imspex provides cutting-edge analytics solutions where early warning signals are needed. Our versatile combination of gas chromatography (GC) and ion mobility spectrometry (IMS) has already proven itself in medical detection and medical diagnosis ...
based inMarche-en-Famenne, BELGIUM
Beldico is a manufacturer and supplier of various medical devices and is active in the production and sales of hospital care commodities and high value medical single-use devices for various medical fields. Beldico manufactures and promotes through ...
based inRostock, GERMANY
Since 2006, CENTOGENE has helped physicians diagnose thousands of rare disease patients around the world. A quick and accurate diagnosis can end an odyssey of medical tests and visits to multiple medical specialists. It also helps physicians better ...
CentoICU – Genetic Testing When Every Moment Counts. Up to one-third of all babies and children admitted to the ICU have a genetic disease. For many patients, early identification can make a difference in ...
based inMerion, PENNSYLVANIA (USA)
Glycotest is a liver disease diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis. Founded in 2012 by NetScientific plc on technology originating at the Baruch S. Blumberg ...
Glycotest blood tests are being developed to provide information on the likelihood of serious liver disease like cancer or fibrosis-cirrhosis by employing technology designed to measure two kinds of disease signals: The amount of the monosaccharide ...
based inStaten Island, NEW YORK (USA)
The SensitivE Audit is a health level assessment device that can detect diseases at the early stages, when there are no florid symptoms, and offers the highest accuracy of up to 97%. Thanks to the joint work of physicists, physicians and computer ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Autoimmune disease is caused by the breaking of self-tolerance. Oncimmune’s understanding of the immune system as a mediator of disease powers the ImmunoINSIGHTS service for autoimmune ...
based inLondon, UNITED KINGDOM
Applied Nanodetectors was formed in 2004 and is a leading developer and supplier of nanosensor based solutions for environmental, healthcare and medical worldwide markets. Improving peoples quality of life with our products. Dedicated to delivering ...
Exhale-Dx™ Is A Non-Invasive Point Of Care Device, That Implements Breath Analysis To Forecast Your Future Diagnosis. This Provides The Patient With Personalised ...
based inSan Diego, CALIFORNIA (USA)
Cortechs.ai is the leader in radiology AI applications, using cutting-edge advances in medical imaging to revolutionize disease screening and early detection so patients can enjoy longer, better lives. The company develops and markets breakthrough ...
based inSuzhou, CHINA
DX Fluidics is situated in the Suzhou Industrial Park, known for its technological and industrial advancements. Specializing in fluid control solutions, the company provides high-quality products designed to optimize fluid management systems across ...
Microfluidic chips are instrumental in advancing research in cell biology and medical science. These chips integrate microfluidics and cell biology to simulate and study cell cycles, molecular and biological processes. They utilize precise ...
based inIpswich, UNITED KINGDOM
Safewater was founded in 1999 with the objective of introducing a safe, non-chemical product that could control Legionella. It was set up at a time when active ceramics first became available, and using this technology, the company developed a ...
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
based inFayetteville, ARIZONA (USA)
Cardiowise connects cardiac CT data with innovative new artificial intelligence (AI) algorithms that augment human decision-making within existing clinical workflows. An accurate diagnosis is the first step to preventing heart disease. CardioWise's ...
Cardiowise connects cardiac CT data with innovative new artificial intelligence (AI) algorithms that augment human decision-making within existing clinical ...
